KoBioLabs, Inc (348150.KQ)
KOSDAQ · KRW · Healthcare · Biotechnology
₩2,750 (+5.16%) as of
Key statistics
- Market cap
- 53.40B
- Dividend yield
- 0.00%
- 52-week range
- 2,310.00 – 8,730.00
- Beta
- 0.11
- Revenue (TTM)
- 75.41B
- Profit margin
- -6.37%
- Volume
- 18.07k
About KoBioLabs, Inc
KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and brain diseases. The company was founded in 2014 and is based in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Seoul, South Korea
- Employees
- 51
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.